Trial · NCT02668146
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Tremor reduction. TETRAS scale, performance sub scale. | 40 weeks | This scale evaluates tremor of various body parts during postures, movement and tasks. Items are scored from 0 to 4, with 4 representing highest severity. Maximum score is 64. |
| Primary | Tremor reduction. TETRAS scale. Activity of Daily Living subscale. | 40 weeks | The subject rates to what extent tremor affects activities in a 12-item, 0-to-4 scale. Maximum score is 48. |
| Primary | Tremor reduction. TETRAS scale. Subject Global Impression of Change. | 40 weeks | Subjects rate the degree of change from minus 3 to plus 3. |
| Primary | Tremor reduction. TETRAS scale. QUEST subscale (QUality of life in Essential Tremor). | 40 weeks | 30-item questionnaire in which the subject rates on a 0 to 4 scale how much tremor affects aspects of life. |
| Primary | Safety. vitals; | 40 weeks | Weight (lbs), respiration rate (rps), heart rate (bps) and blood pressure (mmhg). |
| Primary | Tolerability. Adverse Events. | 40 weeks | At each clinic and phone visit, the PI and coordinator will collect information on any adverse events. An Adverse Event will be defined as any clinically undesirable event. |
| Primary | Safety; laboratory testing | 40 weeks | At each clinic visit. Laboratory testing will be done. This will include metabolic panel (serum electrolytes, glucose (mg/dl) , creatinine (mg/dl) , calcium (mg/dl), magnesium (mg/dl), Complete Blood Count(CBC) (mg/dl), White Blood Count (WBC) (k/ul), platelets (k/ul), hepatic panel (total BILIRUBIN, Total PROTEIN, ALKALINE PHOSPHATASE, ALANINE AMINOTRANSFERASE, ASPARTATE AMINOTRANSFERASE, ALBUMIN GLUTAMYL TRANSFERASE LDH), and urinalysis. |
| Primary | Safety. Laboratory testing; screen visit testing | screen visit | Screen Visit testing will include hemoglobin A1c (%), free thyroxin (ng/dl), and Thyroid Stimulating Hormone (TSH) (uIU/mL) . An EKG will be performed. |
| Secondary | Treatment effects on Daily Living (The QUEST scale to assess quality of life) | 40 weeks | Assess the effect of treatment on tremor-affected activities of daily living. The QUEST scale to assess quality of life in essential tremor. It is a 30-item questionnaire in which the subject rates on a 0 to 4 scale how much tremor affects aspects of life |
| Secondary | QOLIE changes | 40 weeks | Assess changes in Quality Of Life (QOLIE). |
| Secondary | Subjective assessment of global life changes | 40 weeks | Assess subject global impression of change as a result of treatment |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02668146/registered